Rothschild Investment LLC Mirum Pharmaceuticals, Inc. Transaction History
Rothschild Investment LLC
- $1.49 Trillion
- Q1 2025
A detailed history of Rothschild Investment LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 75 shares of MIRM stock, worth $3,258. This represents 0.0% of its overall portfolio holdings.
Number of Shares
75
Previous 45
66.67%
Holding current value
$3,258
Previous $1.86 Million
81.57%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding MIRM
# of Institutions
216Shares Held
53.8MCall Options Held
2.6KPut Options Held
99.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$285 Million16.29% of portfolio
-
Janus Henderson Group PLC London, X04.58MShares$199 Million0.1% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$141 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$122 Million4.33% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$113 Million2.07% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.6B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...